Bromodomain Inhibitor Review: Bromodomain and Extra-terminal Family Protein Inhibitors as a Potential New Therapy in Central Nervous System Tumors

Por Wadhwa, Elizabeth, Nicolaides, Theodore
Publicado no Cureus (2016)

MB-19 MEDULLOBLASTOMA SUBTYPES SPECIFY INTER-TUMORAL VASCULAR BLOOD BRAIN BARRIER HETEROGENEITY

Por Phoenix, Timothy, Patmore, Deanna, Boop, Scott, Jacus, Megan, Patel, Yogesh, Goumnerova, Lilian, Perreault, Sebastien, Wadhwa, Elizabeth, Cho, Yoon-Jae, Stewart, Clinton, Gilbertson, Richard
Publicado no Neuro Oncol (2015)

MB-32 MEDULLOBLASTOMA GENOTYPE DICTATES BLOOD BRAIN BARRIER PHENOTYPE

Por Phoenix, Timothy, Patmore, Deanna, Boop, Scott, Boulos, Nidal, Jacus, Megan, Patel, Yogesh, Roussel, Martine, Finkelstein, David, Goumnerova, Liliana, Perreault, Sebastien, Wadhwa, Elizabeth, Cho, Yoon-Jae, Stewart, Clinton, Gilbertson, Richard
Publicado no Neuro Oncol (2016)

Medulloblastoma genotype dictates blood brain barrier phenotype

Por Phoenix, Timothy N., Patmore, Deanna M., Boop, Scott, Boulos, Nidal, Jacus, Megan O., Patel, Yogesh T., Roussel, Martine F, Finkelstein, David, Goumnerova, Lilian, Perreault, Sebastien, Wadhwa, Elizabeth, Cho, Yoon-Jae, Stewart, Clinton F., Gilbertson, Richard J.
Publicado no Cancer Cell (2016)